HomeCompareNPPGF vs JNJ

NPPGF vs JNJ: Dividend Comparison 2026

NPPGF yields 11.68% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NPPGF wins by $1242535.76M in total portfolio value
10 years
NPPGF
NPPGF
● Live price
11.68%
Share price
$17.13
Annual div
$2.00
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1242535.79M
Annual income
$1,222,427,936,933.22
Full NPPGF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — NPPGF vs JNJ

📍 NPPGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNPPGFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NPPGF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NPPGF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NPPGF
Annual income on $10K today (after 15% tax)
$992.69/yr
After 10yr DRIP, annual income (after tax)
$1,039,063,746,393.24/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, NPPGF beats the other by $1,039,063,742,407.25/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NPPGF + JNJ for your $10,000?

NPPGF: 50%JNJ: 50%
100% JNJ50/50100% NPPGF
Portfolio after 10yr
$621267.91M
Annual income
$611,213,970,811.31/yr
Blended yield
98.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

NPPGF
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NPPGF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNPPGFJNJ
Forward yield11.68%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$1242535.79M$30.3K
Annual income after 10y$1,222,427,936,933.22$4,689.40
Total dividends collected$1241181.57M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NPPGF vs JNJ ($10,000, DRIP)

YearNPPGF PortfolioNPPGF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$13,036$2,335.74$10,592$272.30+$2.4KNPPGF
2$19,639$5,691.25$11,289$357.73+$8.3KNPPGF
3$37,041$16,026.85$12,123$472.89+$24.9KNPPGF
4$96,134$56,499.93$13,141$629.86+$83.0KNPPGF
5$376,949$274,086.00$14,408$846.81+$362.5KNPPGF
6$2,412,148$2,008,812.36$16,021$1,151.60+$2.40MNPPGF
7$26,608,390$24,027,391.79$18,122$1,588.22+$26.59MNPPGF
8$523,884,071$495,413,093.83$20,930$2,228.20+$523.86MNPPGF
9$18,792,387,161$18,231,831,204.81$24,792$3,191.91+$18792.36MNPPGF
10$1,242,535,791,196$1,222,427,936,933.22$30,274$4,689.40+$1242535.76MNPPGF

NPPGF vs JNJ: Complete Analysis 2026

NPPGFStock

Nippon Gas Co., Ltd. engages in the supply and sale of LP gas and natural gas in Japan. It operates through LP Gas Business, Electricity Business, and City Gas Business segments. The company supplies LP gas through pipelines to homes built for sale, company dormitories, apartment buildings, other residential apartment complexes, as well as for commercial, industrial, agricultural, and automotive use; and high-pressure gas for commercial and industrial use. It also sells glass-top stoves, built-in stoves, gas oven ranges, gas rice cookers, dishwashers; gas water heaters, instant water heaters, floor heating products, bathroom heater/ventilation/dryer combo systems, and mist saunas; and commercial and industrial gas appliances. In addition, the company sells air-conditioning equipment, including gas and absorption heat pumps, cogeneration systems, and gas infrared heaters; remodeling-related equipment; and household equipment, as well as offers accident insurance agency services. Further, it engages in residential remodeling and consulting business; and the construction of gas, water supply, drainage, and air conditioning/heating equipment. Additionally, the company is involved in the electric power and gas business. Nippon Gas Co., Ltd. was founded in 1955 and is based in Tokyo, Japan.

Full NPPGF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this NPPGF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NPPGF vs SCHDNPPGF vs JEPINPPGF vs ONPPGF vs KONPPGF vs MAINNPPGF vs ABBVNPPGF vs MRKNPPGF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.